Endocannabinoids as positive or negative factors in hematopoietic cell migration and differentiation

European Journal of Pharmacology

Volumn 595, Issue 1-3, 2008, Pages 1-6

  Patinkin, Deborah ^a   Milman, Garry ^a   Breuer, Aviva ^a   Fride, Ester ^b   Mechoulam, Raphael ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b ARIEL UNIVERSITY   (Israel)

Author keywords

Cannabinoid receptor CB1; Cannabinoid receptor CB2; Ethanolamide cannabinoids; Glycerol cannabinoids

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 2 LINOLEOYLGLYCEROL; 2 MYRISTOYLGLYCEROL; 2 PALMITOYLGLYCEROL; ANANDAMIDE; ARACHIDONIC ACID; ARACHIDONOYLSERINE; CANNABIDIOL; ENDOCANNABINOID; ERYTHROPOIETIN; LINOLEIC ACID; LINOLEOYLETHANOLAMIDE; MYRISTIC ACID; MYRISTOYLETHANOLAMIDE; PALMIDROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; COLONY FORMING UNIT GEMM; CONTROLLED STUDY; DRUG EFFECT; ERYTHROCYTE; ERYTHROID CELL; GRANULOCYTE; HEMATOPOIETIC CELL; MACROPHAGE; MEGAKARYOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; ENDOCANNABINOIDS; GLYCEROL; HEMATOPOIETIC STEM CELLS; MICE; MICE, INBRED C3H; POLYUNSATURATED ALKAMIDES; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2;

EID: 52049093883     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.05.002     Document Type: Article

References (19)

1. Blazquez C., Casanova M.L., Planas A., Del Pulgar T.G., Villanueva C., Fernandez-Ascenero M.J., Aragones J., Huffman J.W., Jorcano J.L., and Guzman M. Inhibition of tumor angiogenesis by cannabinoids. FASEB J. 17 (2003) 529-531
2. Debili N., Coulombel L., Croisille L., Katz A., Guichard J., Breton-Gorius J., and Vainchenker W. Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow. Blood 88 (1996) 1284-1296
3. Deroq J.M., Jbilo O., Bouaboula M., Segui M., Clere C., and Casellas P. Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60. Possible involvement of the CB2 receptor in cell differentiation. J. Biol. Chem. 275 (2000) 15621-15628
4. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Ettinger A., and Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258 (1992) 1946-1949
5. Jorda M.A., Verbakel S.E., Valk P.J., Vankan-Berkhoudt Y.V., Maccarrone M., Finazzi-Agro A., Lowenberg B., and Delwel R. Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol. Blood 99 (2002) 2786-2793
6. Joseph J., Niggemann B., Zaenker K.S., and Entscladen F. Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes. Cancer Immunol. Immunother. 53 (2004) 723-728
7. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., Compton D.R., Pertwee R.G., Griffin G., Bayewitch M., Barg J., and Vogel Z. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50 (1995) 83-90
8. Milman G., Maor Y., Abu-Lafi S., Horowitz M., Gallily R., Batkai S., Mo F.-M., Offertaler L., Pacher P., Kunos G., and Mechoulam R. N-Arachidonoyl l-serine, a novel endocannabinoid-like brain constituent with vasodilatory properties. PNAS 103 (2006) 2428-2433
9. Mo F.M., Offertaler L., and Kunos G. Atypical cannabinoid stimulates endothelial cell migration via a G1/Go-coupled receptor distinct from CB1, CB2 or EDG-1. Eur. J. Pharmacol. 489 (2004) 21-27
10. Patinkin D., Seidman S., Eckstein F., Benseler F., Zakut H., and Soreq H. Manipulations of cholinesterase gene expression modulate murine megakaryocytopoiesis in vitro. Mol. Cell Biol. 10 (1990) 6046-6050
11. Pertwee R.G. Pharmacological actions of cannabinoids. Handb. Exp. Pharmacol. 168 (2005) 1-51
12. Rossato M., Ion Popa F., Ferigo M., Clari G., and Foresta C. Human sperm express cannabinoid receptor Cb1, the activation of which inhibits motility, acrosome reaction, and mitochondrial function. J. Clin. Endocrinol. Metab. 90 (2005) 984-991
13. Sacerdote P., Massi P., Panerai A.E., and Parolaro D. In vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors. J. Neuroimmunol. 109 (2000) 155-163
14. Song Z.H., and Zhong M. CB1 Cannabinoid receptor-mediated cell migration. J. Pharmacol. Exp. Ther. 294 (2000) 204-209
15. Stanley E.R., Bartocci A., Patinkin D., Rosendaal M., and Bradley T.R. Regulation of very primitive, multipotent hematopoietic cells by hemopoietin-1. Cell 45 (1986) 667-674
16. Sulcova E., Mechoulam R., and Fride E. Biphasic effects of anandamide. Pharmacol. Biochem. Behav. 59 (1998) 347-353
17. Valk P., Verbakel S., Vankan Y., Hol S., Mancham S., Ploemacher R., Mayen A., Lowenberg B., and Delwel R. Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells. Blood 90 (1997) 1448-1457
18. Vaccani A., Massi P., Colombo A., Rubino T., and Parolaro D. Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism. Br. J. Pharmacol. 144 (2005) 1032-1036
19. Walter L., Franklin A., Witting A., Wade C., Xie Y., Kunos G., Mackie K., and Stella N. Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J. Neurosci. 23 (2003) 1398-1405